Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $35
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $30 to $35.
Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $30 to $35.